Demand for Biological Indicator Vial in USA Expands at 4.4% CAGR Through 2035 with West and South Dominance as Mesa Labs
The Demand for Biological Indicator Vials in the USA is projected to grow from USD 59.6 million in 2025 to USD 91.4 million by 2035, reflecting a steady CAGR of 4.4%. Growth is being driven by stricter sterilization validation requirements across pharmaceuticals, biotechnology, healthcare, and medical device manufacturing, where sterility is essential for...
0 التعليقات 0 المشاركات 15 مشاهدة 0 معاينة